Methodist Hospitals Selects Philips to Advance Neurovascular, Cardiology and Complex Interventional Radiology Services in Northwest Indiana
Methodist Hospitals will utilize one Philips Azurion biplane for both routine and complex procedures – such as active stroke intervention – designed to speed up and improve minimally invasive treatment. The health system will also standardize care on two single plane labs for cardiovascular care and a multi-purpose lab for complex cardiovascular and interventional radiology procedures. The Philips Azurion system has been shown to improve operational and clinical efficiency in the interventional suite while maintaining high quality care and staff satisfaction, including a 17% reduction in procedure time, providing the ability to treat one more patient per day [1].
'Having leading edge health technology is crucial to delivering on our mission to be the best place for employees to work, for patients to receive care and for physicians to practice medicine,' said Matt Doyle, President & Chief Executive Officer, Methodist Hospitals. 'Philips' trusted solutions will empower us to deliver exceptional care to our patients close to home. Our collaboration with Philips enables us to maintain the highest standards of care now and into the future, reinforcing our commitment to excellence in healthcare delivery.'
Methodist Hospitals is an award-winning healthcare provider that offers comprehensive services including emergency care, surgical services, oncology and cardiology, and is home to the Heart and Vascular Institute and NeuroScience Institute. The health system has more than 500 inpatient beds and more than 400 physicians and allied health professionals.
'These new interventional suites represent a significant step forward in fulfilling Methodist Hospitals' commitment to providing the highest level of care for every patient they serve,' said Jeff DiLullo, Chief Region Leader, Philips North America. 'Philips is proud to support these clinicians in making the right decisions faster, treating more patients more effectively, and achieving better health outcomes for their community with some of the most advanced interventional suites in the industry. We look forward to working closely with Methodist Hospitals to continue to transform the health of citizens in Northwest Indiana.'
The Philips Azurion Image-Guided Therapy System with FlexArm and ClarityIQ technology provides exceptional imaging with reduced X-ray dose [2], improved workflow and more efficient turnaround times [1], offering a high level of clinical confidence. Methodist Hospitals will also benefit from Philips' IntraSight with SyncVision for IVUS imaging and additional physiology and interventional tools to simplify complex interventions, speed routine procedures and provide improved patient care [3,4]. Control of all compatible applications from a single touchscreen at the tableside helps clinicians make fast and informed decisions without breaking sterility.
[1] Results from study conducted at St. Antonius Hospital. Results verified by NAMSA, independent third-party expert on study design and analytics. Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions.
[2] In 37 individual comparative studies, Philips ClarityIQ was associated with reductions in patient radiation exposure. The results of the application of dose reduction techniques will vary depending on the clinical task, patient size, anatomical location and clinical practice. The interventional radiologist assisted by a physicist as necessary has to determine the appropriate settings for each specific clinical task.
[3] Rao, Sunil V et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology, S0735-1097(24)10424-X. 27 Feb. 2025, doi:10.1016/j.jacc.2024.11.009.
[4] Lawton J. et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. JACC. 2022;79(2):e21-e129. 2024.
About Methodist Hospitals
Methodist Hospitals is a community-based, not-for-profit health system with two full-service acute care facilities in Gary and Merrillville, Indiana, that has been healing Northwest Indiana for more than 100 years. Methodist Hospitals offers a number of award-winning programs, including its Breast Care Center, Cancer Center and Neuroscience and Heart and Vascular Institutes. Its range of services also includes Women & Children's Services, Bariatric Surgery services, Emergency services, Immediate Care Centers, Orthopedics & Spine services, comprehensive Rehabilitation services, Behavioral Health and Home Health services.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,200 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
*The opinions and clinical experiences presented herein are specific to the featured topic(s) and are not linked to any specific patient and are for information purposes only. The medical experience(s) derived from specified topic(s) may not be predictive of all patients. Individual results may vary depending on a variety of patient-specific attributes and related factors. Nothing in this news announcement is intended to provide specific medical advice or to take the place of written law or regulations.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Why Gorman-Rupp (GRC) Stock Is Up Today
What Happened? Shares of gorman-Rupp (NYSE:GRC) manufactures and sells pumps globally. jumped 7.6% in the afternoon session after the company reported record second-quarter financial results that surpassed analyst expectations, driven by strong sales linked to infrastructure spending. The industrial pump manufacturer posted earnings of $0.60 per share on a record $179 million in revenue, surpassing analyst expectations. This performance marked a significant improvement compared to the $0.32 per share reported in the same quarter last year. The revenue growth was primarily fueled by a $3.5 million increase in sales to the municipal market, which the company attributed to infrastructure investment. The fire suppression, industrial, and petroleum markets also contributed to the gains. In a further sign of strength, Gorman-Rupp announced record incoming orders of $188 million, up 15.7% from the prior year, which suggested a positive outlook for the second half of the year. Is now the time to buy Gorman-Rupp? Access our full analysis report here, it's free. What Is The Market Telling Us Gorman-Rupp's shares are not very volatile and have only had 5 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business. The biggest move we wrote about over the last year was 4 months ago when the stock dropped 5.1% after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%, while the baseline 10% tariffs remained in place for all countries. This reminded markets that the global trade environment remained volatile, limiting the potential for sustained gains. Also, President Trump said he was willing to accept pain in the short term, and was aware his policies could cause a recession, but he remained more mindful of a more severe case of economic depression (higher unemployment and prolonged downturn). For investors, this suggested that the administration could prioritize long-term structural shifts over near-term economic stability, further increasing policy-driven risk in the markets. Gorman-Rupp is up 11.2% since the beginning of the year, and at $41.46 per share, it is trading close to its 52-week high of $43.09 from November 2024. Investors who bought $1,000 worth of Gorman-Rupp's shares 5 years ago would now be looking at an investment worth $1,295. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
Why Centene (CNC) Stock Is Trading Up Today
What Happened? Shares of health coverage company Centene (NYSE:CNC) jumped 5.9% in the afternoon session after the company reported second-quarter results that missed earnings estimates, but the stock rallied as investors looked past the disappointment as sales came in ahead of expectations. Centene posted its first quarterly earnings miss in four years, swinging to an adjusted loss per share of $0.16, a stark contrast to the profit recorded in the same quarter last year. The company also set its 2025 earnings guidance significantly below analyst expectations, citing worse-than-expected cost trends in its Affordable Care Act (ACA) Marketplace business. Despite the profitability issues, total revenues for the quarter came in strong at $48.7 billion, handily beating expectations. While the stock initially dropped sharply in pre-market trading on the earnings miss, it reversed course and rallied during the company's earnings call. This turnaround suggested investors may have gained confidence from management's commentary and their stated plan to address the cost issues and restore profitability. Is now the time to buy Centene? Access our full analysis report here, it's free. What Is The Market Telling Us Centene's shares are somewhat volatile and have had 13 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 7 days ago when the stock dropped 3.9% as several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively. Additionally, some pharmaceutical and biotech companies experienced sharp drops following unfavorable news; for instance, Sarepta Therapeutics plunged after a report indicated another patient death tied to its experimental gene therapy, and GSK's blood cancer drug dosage was voted against by the FDA advisory committee. Broader market sentiment, including concerns about rising costs and inadequate pricing for 2025 plans among health insurers, also contributed to the downward pressure on healthcare equities. Centene is down 53.3% since the beginning of the year, and at $28.29 per share, it is trading 64.7% below its 52-week high of $80.23 from September 2024. Investors who bought $1,000 worth of Centene's shares 5 years ago would now be looking at an investment worth $420.47. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
Yahoo
20 minutes ago
- Yahoo
Empire Petroleum Announces Extension of Previously Announced Rights Offering and Clarifies Unit Subscription Price
TULSA, Okla., July 25, 2025--(BUSINESS WIRE)--Empire Petroleum Corporation (NYSE American: EP) ("Empire" or the "Company"), an oil and gas company with current producing assets in New Mexico, North Dakota, Montana, Texas, and Louisiana, announced today that it has extended the expiration date and clarifies the unit subscription price of its previously announced subscription rights offering ("Rights Offering") pursuant to which it intends to raise gross proceeds of up to approximately $5.0 million, including $2.5 million from the exercise of the warrants issued as part of the Rights Offering. The Company is distributing at no charge to holders of its common stock, par value $0.001 per share ("Common Stock"), as of the close of business on July 10, 2025 (the record date for the Rights Offering), one subscription right for each share of Common Stock held. Each subscription right entitles the holder to purchase one unit at a subscription price of $0.07367 per unit, each unit consisting of 0.0139 shares of Common Stock and one warrant exercisable for 0.0136 shares of Common Stock at $5.46 per whole share. As a result, a stockholder must hold at least 72 shares of Common Stock to receive subscription rights to purchase at least one whole share at $5.30 per share, as well as at least 74 shares of Common Stock to receive warrants to purchase one whole share at $5.46 per share. The subscription rights and warrants are non-transferable, and will not be listed for trading on any stock exchange or market. In addition, holders of subscription rights who fully exercise their subscription rights are entitled to over-subscribe for additional units, subject to proration. For example, if you owned 100 shares of our Common Stock on the record date, you would be granted subscription rights to purchase an aggregate of 1.39 shares of Common Stock and warrants exercisable for 1.36 shares of Common Stock at the subscription price. If you are entitled to receive a fraction of a share, we will round down the number of shares to which you are entitled to purchase to the nearest whole number. As such, for the above example, you would receive 1 share of Common Stock and 1 warrant due to rounding. The Rights Offering is now expected to expire at 5:00 p.m., Eastern Time, on August 18, 2025 ("Expiration Date"), subject to extension or earlier termination. The Company has extended the expiration date in order to allow its stockholders to have more time to consider their participation and arrange finances for the Rights Offering. We had previously set the subscription price at $5.30 per unit, but adjusted the subscription price to $0.07367 per unit to more accurately reflect the intended terms of the offering. Phil E. Mulacek, Chairman of the Board of Empire and one of the Company's largest shareholders, has indicated that he intends to participate in the Rights Offering and fully subscribe to the units corresponding to his subscription rights. He has also indicated that he intends to fully exercise his over-subscription rights to purchase his pro rata share of the underlying securities related to the Rights Offering that remain unsubscribed at the Expiration Date. Holders of subscription rights who hold their shares directly have received a prospectus, a prospectus supplement, a letter from Empire describing the Rights Offering, and a subscription rights certificate. Empire will also be providing an additional prospectus supplement regarding the updated terms noted in this news release. Those holders who intend to exercise their subscription rights and over-subscription rights should review all of these materials, properly complete and execute the subscription rights certificates, and deliver the subscription rights certificates and full payment to Securities Transfer Corporation, the subscription agent for the Rights Offering, at the address set forth in the prospectus supplements referenced below. The Rights Offering is more fully described in the prospectus supplement filed with the Securities and Exchange Commission ("SEC") on July 10, 2025, as supplemented by the prospectus supplements filed with the SEC on July 24, 2025 and July 25, 2025. A copy of the prospectus, prospectus supplements or further information with respect to the Rights Offering may be obtained by contacting Securities Transfer Corporation, the subscription and information agent for the Rights Offering, at (469) 633-0101. This news release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any offer, solicitation or sale of securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. About Empire Petroleum Empire Petroleum Corporation is a publicly traded, Tulsa-based oil and gas company with current producing assets in New Mexico, North Dakota, Montana, Texas, and Louisiana. Management is focused on organic growth and targeted acquisitions of proved developed assets with synergies with its existing portfolio of wells. More information about Empire can be found at Safe Harbor Statement This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements involve a wide variety of risks and uncertainties, and include, without limitations, statements with respect to the Company's estimates, strategy and prospects. Such statements are subject to certain risks and uncertainties which are disclosed in the Company's reports filed with the SEC, including its Form 10-K for the fiscal year ended December 31, 2024, and its other filings with the SEC. Readers and investors are cautioned that the Company's actual results may differ materially from those described in the forward-looking statements due to a number of factors, including, but not limited to, the Company's ability to acquire productive oil and/or gas properties or to successfully drill and complete oil and/or gas wells on such properties, general economic conditions both domestically and abroad, and other risks and uncertainties related to the conduct of business by the Company. Other than as required by applicable securities laws, the Company does not assume a duty to update these forward-looking statements, whether as a result of new information, subsequent events or circumstances, changes in expectations, or otherwise. View source version on Contacts Empire Petroleum Corporation:Mike MorrisettPresident and CEO539-444-8002info@ Kali CarterCommunications & Investor Relations Manager918-995-5046IR@
